Navigation Links
Transposagen Expands Field of Use for piggyBac Technology
Date:10/15/2009

LEXINGTON, Ky., Oct. 15 /PRNewswire/ -- Transposagen Biopharmaceuticals, Inc. based in Lexington, KY announced today that it has come to an agreement to expand its license for piggyBac technology to cover nearly all commercial applications. The intellectual property, owned jointly by the University of Notre Dame, the University of Florida and the United States Department of Agriculture, enables facile genetic manipulation of most species. It is the core technology used by Transposagen to create TKO(TM) Knockout Rat Models, laboratory rats with a single gene disruption that mimic human disease.

The laboratory of Dr. Malcolm J. Fraser, Jr. at the University of Notre Dame has been responsible for the early characterization and development of the piggyBac DNA transposon. PiggyBac is a highly versatile technology that is used for genetic engineering in almost any animal, allowing for both mutagenesis (changing or disrupting genes) and transgenesis (adding genes). PiggyBac is now enabling genetic manipulation for a wide range of important species including research animals and agriculturally important animals for which genetic manipulation was previously impossible or cost-prohibitive.

"Transposagen was already in the process of using piggyBac to generate tens of thousands of knockout rat lines in a very short period of time. We will now be able to use piggyBac to modify the genomes of other important organisms," said Dr. Eric Ostertag, CEO of Transposagen Biopharmaceuticals, Inc. "PiggyBac is also finding uses in human therapeutics as it can be used to
'/>"/>

SOURCE Transposagen Biopharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Transposagen Creates a Rat Model of the Human Immune System
2. Cepheid Expands Leadership Team With Appointment of Executive Vice President of Worldwide Commercial Operations
3. Nobelprize.org Expands Channels and News Services for the 2009 Nobel Prize Announcements
4. Caliper Life Sciences Expands Suite of Reagents Supporting the IVIS Family of In Vivo Imaging Systems
5. Medelis Expands CRO Services to Medical Devices, Appoints Dr. Inder Makin as VP
6. OmniComm Systems Inc. Expands Its Successful CRO Preferred Program(TM) By Signing On Three New CRO Partners
7. Avid Bioservices Expands Executive Team as it Prepares for Continued Growth
8. Ajinomoto Food Ingredients LLC Expands Capabilities
9. Abbott Expands XIENCE V(R) USA Trial to Enroll Patients into Landmark Dual Anti-Platelet Therapy (DAPT) Trial
10. Texcel Medical Expands Medical Device Development & Manufacturing Capabilities With New Personnel, Nearly $1 Million in Capital Investments
11. McKesson Expands Pharmacy Automation Product Portfolio to Include I.V. Therapy

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)... Synthesis Companies Form International Gene Synth...s in Risk Reduction ,Five Member Companies Repre...ty , (PRWEB) November 19,...nthesis companies today announced agreement that t...ote biosecurity in the gene synthesis industry. B...
(Date:11/18/2009)...tandards and Technology (NIST) has demonstrated a ...g and measuring elusive hazards such as concealed ...or pesticides distributed in soil by wind and rain...entional techniques for detecting traces of these ...ving distinct electrically positive and negative e...
(Date:11/18/2009)...ewswire-FirstCall/ -- Sangamo BioSciences, Inc. (N...University of Pennsylvania investigator sponsored ...ease (ZFN) based product, SB-728-T, for HIV/AIDS w... internet. ,, Data were presented in a student ... Medicine from a single subject treated with SB-72...
(Date:11/18/2009)...ire/ -- Reportlinker.com announces that a new mark...,, Biotechnology Reagents - A Global Market P...0164375/Biotechnology-Reagents---A-Global-Market-P...um=pr&utm_campaign=prnewswire ,, Reagents...nds used in a range of biotech related areas inclu...
Breaking Biology Technology:World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4Prototype NIST method detects and measures elusive hazards 2Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 3Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 4Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 5Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 6Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 7Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 8
... Training Physician for both Botox and Fraxel...st in Orange County begins in-office clinical proc...Botox as a pre-treatment to enhance the improvemen... this study will be resistant lip lines in women o...ge County, CA (PRWEB) January 1, 2009 -- To find a...
...lif., Jan. 2 Valeant,Pharmaceuticals Internationa...cember 31, 2008, the company completed its acquisi...tely held dermatology company that specializes in ...ry basis, as well as for,pharmaceutical and biotec...nt Pharmaceuticals International (NYSE: VRX ) is...
...if., Jan. 2 Bionovo, Inc.,(Nasdaq: BNVI ) annou...,regulatory elements that can be used to identify ...ed in Molecular and Cellular Endocrinology, showed...the estrogenic,pharmacological activity exerted by...rediction of specific tissue effect. , "Select...
Other Biology Technology:Irvine Dermatologist Begins In-office Clinical Studies -- Nissan Pilest, MD Combines Multi-Use Botox in Laser Resurfacing Clinical Studies 2Irvine Dermatologist Begins In-office Clinical Studies -- Nissan Pilest, MD Combines Multi-Use Botox in Laser Resurfacing Clinical Studies 3Bionovo Publishes Discoveries in Predictable Tissue Selectivity for Selective Estrogen Receptor Modulators Platform 2Bionovo Publishes Discoveries in Predictable Tissue Selectivity for Selective Estrogen Receptor Modulators Platform 3
(Date:11/20/2009)...2009 The estimated 4.6 million Americans involved...ng respiratory symptoms due to poor air quality in...ndertaken earlier this year by investigators at Tu...icine. , The studywhich polled more than 80 New ... individuals working in barns complained of coughi...
(Date:11/20/2009)...acterial gene into yeast, researchers from Delft U...d three improvements in bioethanol production from...acetate and elimination of the major by-product gl...he scientific journal Applied and Environmental M...e by the yeast Saccharomyces cerevisiae from sugar...
(Date:11/20/2009)...an . , In the current online issue of the J...erich and Dr. Kilian Eyerich together with their c...o Dermopatico dell,Immacolata in Rome, present the...tone on the way to developing new treatment method... and allergic reactions and potentially also aller...
Breaking Biology News(10 mins):Barn personnel experience higher-than-average rates of respiratory symptoms 2Delft breakthrough in bioethanol production from agricultural waste 2Discovery of new type of immune cells regulating inflammation in chronic diseases 2Econiche 28TM 29 Vaccine Efficacy Summarized in July Issue of Foodborne Pathogens and Disease 51988 1Econiche 28TM 29 Vaccine Efficacy Summarized in July Issue of Foodborne Pathogens and Disease 51988 2Econiche 28TM 29 Vaccine Efficacy Summarized in July Issue of Foodborne Pathogens and Disease 51988 3Econiche 28TM 29 Vaccine Efficacy Summarized in July Issue of Foodborne Pathogens and Disease 51988 4Econiche 28TM 29 Vaccine Efficacy Summarized in July Issue of Foodborne Pathogens and Disease 51988 5Econiche 28TM 29 Vaccine Efficacy Summarized in July Issue of Foodborne Pathogens and Disease 51988 6Center for Medicines 26 Healthy Aging 28C 29 and BidRx 28R 29 Partner to Help Consumers Save on Prescription Medications 51986 1Center for Medicines 26 Healthy Aging 28C 29 and BidRx 28R 29 Partner to Help Consumers Save on Prescription Medications 51986 2Center for Medicines 26 Healthy Aging 28C 29 and BidRx 28R 29 Partner to Help Consumers Save on Prescription Medications 51986 3Potato Tops Poll To Be UKs National Veg 51985 1Potato Tops Poll To Be UKs National Veg 51985 2
...that rats are capable of metacognition—that is, th...ates. This ability, which can also be thought of a...ental processes, was previously only recognized in...ted by Allison Foote and Jonathon Crystal of the U...nal Current Biology, published by Cell Press, on M...
...verproduced in ovarian cancer may present a new ta...er cancers, according to researchers at the Univer...UIC College of Pharmacy found that interfering wit...the growth and invasiveness of tumor cells in test...bserved that human ovarian tumors overexpressed po...
...stem cells from the lungs of transplant patients d...or cells reside in adult organs and are not derive... that the cells may be able to help with the rejec...ung disease. , The study by University of Michiga... of the large number of lung transplant patients w...
Other Biology News:Metacognition: Faced with a test, rats can check their knowledge first 2RNA splicing factor implicated in ovarian tumor cell growth 2Type of stem cell found to reside in transplanted lungs 2Type of stem cell found to reside in transplanted lungs 3
...on inline heater plus multi-channel focal drug del...sh-out with a high-flow bath line while quickly sw...fusion Pencil.® Steady 37°C at 5 ml/minut... Advanced auto-tuning temperature lock Designed f...
Mouse Anti-Integrin alpha M Monoclonal Antibody, Unconjugated, Clone ICRF 44 from Novus Biologicals
Rat Anti-Mouse Amphiregulin Monoclonal Antibody, Unconjugated, Clone 206220 from R&D Systems
Hae III from Takara Mirus Bio
Biology Products: